FTC give go-ahead for Mylan’s $7.2 billion purchase of Meda
July 27, 2016 at 20:58 PM EDT
Mylan NV has received U.S. Federal Trade Commission approval for its roughly $7.2 billion purchase of Swedish rival Meda, conditioned on Mylan divesting rights to two generic drugs.
